Literature DB >> 2787640

Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis.

J D Pauls1, E Silverman, R M Laxer, M J Fritzler.   

Abstract

The specificity of juvenile rheumatoid arthritis (JRA) sera for histone subclasses was examined by immunoblotting. Antibodies to H1 alone were found in 4 of 21 pauciarticular-onset JRA sera, 4 of 19 polyarticular-onset JRA sera, and 2 of 11 systemic-onset JRA sera. Antibodies to H5 alone were found in 1 of 21 pauciarticular JRA sera, 1 of 19 polyarticular JRA sera, and 3 of 11 systemic JRA sera. Antibodies to both H1 and H5 were found in 4 of 21 pauciarticular JRA sera, 4 of 19 polyarticular JRA sera, and 1 of 11 systemic JRA sera. Antibodies to the core histones (H2A and H2B) were found in 1 of 21 pauciarticular JRA sera, 1 of 19 polyarticular JRA sera, and no systemic JRA sera. No reactivity to histones was observed in 30 sera from age-matched children with nonrheumatic diseases. The presence of H1 and H5 antibodies did not correlate with antinuclear antibody titers or with a homogeneous pattern of immunofluorescence. The predominance of H1 and H5 antibodies and relative absence of antibodies binding to core histones in JRA contrast with findings in adult systemic lupus erythematosus. Further, the presence of antibodies to H5 alone in some of the JRA patients indicates that the immune response in these patients is directed to determinants that are not shared by sequences of mammalian proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787640

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

Review 1.  Juvenile chronic arthritis, chronic iridocyclitis, and reactivity to histones.

Authors:  A M Leak; P Woo
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

2.  Antinucleosome antibodies in juvenile chronic arthritis.

Authors:  Renato M Nisihara; Thelma Skare; Marilia Barreto Silva; Rafael Mourato Silva; Danilo J Munhoz Silva
Journal:  Clin Rheumatol       Date:  2009-09-30       Impact factor: 2.980

Review 3.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

4.  Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives.

Authors:  T R Southwood; P J Roberts-Thomson; M J Ahern; K Shepherd; R McEvoy; J B Ziegler; J Edmonds
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

Review 5.  Diversity and origin of rheumatologic autoantibodies.

Authors:  M J Fritzler; M Salazar
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

6.  Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centromere and histone.

Authors:  L Martin; J D Pauls; J P Ryan; M J Fritzler
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

7.  The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis.

Authors:  H Sierakowska; K R Williams; I S Szer; W Szer
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

8.  Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis.

Authors:  K L Zuklys; I S Szer; W Szer
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

9.  Autoantibodies in chronic arthritis of childhood: relations with each other and with histocompatibility antigens.

Authors:  P N Malleson; M Y Fung; R E Petty; M J Mackinnon; M L Schroeder
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

10.  Anti-"dividing cell antigen" autoantibody: a novel antinuclear antibody pattern related to histones in systemic lupus erythematosus.

Authors:  M Blaschek; S Muller; P Youinou
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.